Monday 28 October 2024

Bought NKE, Pru, GSK

 While the bulk of my buying has been ETFs, I still occasionally dabble in individual stocks.

I reinitiated a small position in NKE, 100 shares under $80, and prepared to average down further as I have high conviction that fair value >$80.

Topped up PRU. I feel Pru is undervalued, having been hit by negative China sentiment.

Topped up GSK. As the price has been flatlining, its an opportunity to continue to accumulate.

No comments:

Post a Comment